Finished
Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)
NCT02369211 · Brigham and Women's Hospital · Updated 11 Sept 2019
- What is being tested
- Acetaminophen (Ofirmev); Placebo
- For
- Prostatectomy; Pain
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years to 85 years. About 86 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started Sept 2015, ends March 2018. Registered 23 Feb 2015.
- Results
- Posted on the registry on 11 Sept 2019.
In the researchers' words
To examine pharmacoeconomics of IV acetaminophen (Ofirmev). Specifically, to examine its potential to improve hospital efficiency and patient outcomes. The investigators compare the addition of IV acetaminophen versus placebo on postoperative anesthesia care unit recovery times, inpatient hospital length of stay (LOS), postoperative pain scores, consumption of opiates as rescue agents and side effects among patients undergoing robotic-assisted laparoscopic prostatectomy (RALP).
Sites
- Brigham and Women's HospitalBoston, Massachusetts, United States